Results 1 to 10 of about 1,027,416 (202)

Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021 [PDF]

open access: yesFrontiers in Public Health, 2023
BackgroundCarbapenem-resistant Enterobacterales (CRE) are spreading in the United Arab Emirates (UAE) where their dissemination is facilitated by international travel, trade, and tourism.
Jens Thomsen   +10 more
doaj   +6 more sources

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales

open access: yesAntibiotics, 2023
Metallo-beta-lactamases (MBLs) are enzymes that break down carbapenem antibiotics, leading to carbapenem-resistant organisms. Carbapenemase-resistant Enterobacterales (CRE) is one of them. Outbreaks of CRE infection can occur in healthcare facilities and
Kentarou Takei   +9 more
doaj   +2 more sources

Screening for Fosfomycin Resistance Genes in Carbapenem- Resistant Isolates of Enterobacterales from the Bloodstream of Liver Transplant Patients

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER   +4 more
doaj   +2 more sources

Investigation of New Delhi metallo-beta-lactamase-1 (blandm-1) gene in carbapenem-resistant Enterobacterales strains isolated from a university hospital in Turkey

open access: yesMedicine Science, 2021
In this study, the presence of blaNDM-1 gene in carbapenem-resistant Enterobacterales obtained from various clinical specimen of a University Hospital in Turkey between the years 2014-2019, has been investigated.
Merih Simsek, Cengiz Demir, Esra Seker
doaj   +2 more sources

Metallo-β-lactamase mediated resistance and Class 1 integron in carbapenem-resistant Enterobacterales isolates from the clinical specimens of Nepal [PDF]

open access: yesBMC Microbiology
Background Carbapenem-resistant Enterobacterales (CRE) pose an escalating public health threat due to their limited therapeutic options and their potential for rapid dissemination in healthcare settings. Mobile genetic elements (MGEs), such as integrons,
Manisha Shrestha   +6 more
doaj   +2 more sources

Increase in blaNDM among Carbapenemase-Producing, Carbapenem-Resistant Enterobacterales, United States, 2016–2023 [PDF]

open access: yesEmerging Infectious Diseases
We report an increase of blaNDM among carbapenemase-producing, carbapenem-resistant Enterobacterales collected in the United States through the Emerging Infections Program’s Multi-site Gram-negative Surveillance Initiative.
Uzma Afroz Ansari   +9 more
doaj   +2 more sources

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study

open access: yesJournal of Pure and Applied Microbiology, 2023
In recent years, a wide range of clinical infections are being caused by carbapenem-resistant Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. This is a matter of great concern, as carbapenem-resistant infections have fewer treatment
Gaurav Verma   +6 more
doaj   +1 more source

In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014–2018

open access: yesJournal of Global Antimicrobial Resistance, 2022
: Objectives: Ceftazidime/avibactam (CAZ/AVI) has shown in vitro activity against multidrug-resistant (MDR) Gram-negative bacteria, especially Enterobacterales and carbapenem-resistant Pseudomonas aeruginosa.
Elkin V. Lemos-Luengas, MD, PhD   +3 more
doaj   +1 more source

In Vitro Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019

open access: yesMicrobiology Spectrum, 2022
Novel β-lactam–β-lactamase inhibitor combinations (BLBLIs) are in clinical development for the treatment of infections caused by carbapenem-resistant and difficult-to-treat resistant (DTR) (defined as resistance to all tested β-lactams and ...
Yan Guo   +10 more
doaj   +1 more source

Correlation between Mechanism of Carbapenem Resistance and in vitro Efficacy of Ceftazidime-Avibactam and Meropenem-Vaborbactam on Carbapenem-Resistant Enterobacterales and Pseudomonas Aeruginosa

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To determine the mechanism of Carbapenem resistance, type of Carbapenemase produced and in vitro efficacy of Ceftazidime-Avibactam (CAZ-AVI) and Meropenem-Vaborbactam (MEV) against Carbapenem-resistant Enterobacterales and in vitro efficacy ...
Fatima Ali   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy